Jane Papadaki Markley

30 years’ experience – global clinical Dx marketplace and biotech with commercial leadership roles launching products and services for infectious disease and immunology at Quest Diagnostics and then assays for oncology and genetic diseases at Qiagen and Asuragen and automation and genomic applications at Takara Bio. Successfully pioneered new technologies for emerging pathogens and new biomarkers through surmounting barriers to market entry, creating new markets through distributor networks and/or building and leading commercial teams and setting new standards for clinical diagnosis in Lyme borreliosis, C.pneumoniae, BCR/ABL and Fragile X.